Christopher McGann

Dr. Nassir F. Marrouche is a globally renowned electrophysiologist and pioneer in the treatment of atrial fibrillation and its outcomes. He is a tenured Professor in the Division of Cardiovascular Medicine within the Department of Internal Medicine at Tulane University and is Director of the Cardiac Electrophysiology Division. He initiated a collaborative arrhythmia center that is bringing together a cross-departmental team of physicians, scientists, researchers, MRI and imaging specialists, and digital health experts dedicated to working collaboratively to improve successful prediction, prevention and outcomes in the treatment of cardiovascular disease using innovative approaches and technologies.

Dr. Marrouche is a Fellow of the American College of Cardiology and Heart Rhythm Society (HRS). He recently received the James H. Youngblood Excellence in Leadership Award as the Chair of the Digital Health Committee of HRS. In this position, Dr Marrouche has led multiple initiatives to improve the integration of digital technology into clinical practice. He has published his research findings in more than 200 peer-reviewed articles and prominent medical journals, including the New England Journal of Medicine, Circulation and Journal of the American Medical Association (JAMA).

Moussa Mansour, MD, is the Director of the Atrial Fibrillation Program at Massachusetts General Hospital, Jeremy Ruskin and Dan Starks Endowerd Chair in Cardiogy, and Professor of Medicine at Harvard Medical School

Dr. Mansour is an active clinical consultant in all aspects of heart rhythm disorders, including atrial fibrillation, ventricular tachycardia, supraventricular tachycardia, bradycardia and other abnormal rhythms. Dr. Mansour performs a large number of catheter ablation procedures and left atrial appendage closures.

Dr. Mansour has published extensively in the field of cardiac arrhythmia, specifically the area of Atrial Fibrillation. He is involved in cutting edge research and currently participating in the development of new catheters for the treatment of atrial fibrillation.

Emile Daoud is Director of Cardiac Electrophysiology Research at TriHealth Heart & Vascular Institute, Bethesda North Hospital in Cincinnati, Ohio. He completed Internal Medicine training at Johns Hopkins Hospital in Baltimore, Maryland; and, Cardiology and Electrophysiology training were completed at University of Michigan Hospital in Ann Arbor, Michigan.
Dr. Daoud has co-authored numerous articles, book chapters and other academic manuscripts and serves on multiple editorial boards. His research has focused upon clinical trials in atrial fibrillation ablation, left atrial appendage closure and management of ventricular arrhythmias.